PRELUDE THERAPEUTICS INC's ticker is PRLD and the CUSIP is 74065P101. A total of 61 filers reported holding PRELUDE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 6.00 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $15,000 | -37.5% | 5,063 | -4.1% | 0.00% | – |
| Q2 2023 | $24,000 | -20.0% | 5,279 | +0.4% | 0.00% | – |
| Q1 2023 | $30,000 | +15.4% | 5,258 | +22.3% | 0.00% | – |
| Q4 2022 | $26,000 | -7.1% | 4,299 | +2.4% | 0.00% | – |
| Q3 2022 | $28,000 | +115.4% | 4,200 | +67.9% | 0.00% | – |
| Q2 2022 | $13,000 | -40.9% | 2,501 | -21.0% | 0.00% | – |
| Q1 2022 | $22,000 | -63.9% | 3,166 | -34.5% | 0.00% | – |
| Q4 2021 | $61,000 | -60.1% | 4,832 | -1.5% | 0.00% | – |
| Q3 2021 | $153,000 | +47.1% | 4,906 | +34.2% | 0.00% | – |
| Q2 2021 | $104,000 | -30.7% | 3,656 | +6.0% | 0.00% | – |
| Q1 2021 | $150,000 | -26.1% | 3,449 | +21.8% | 0.00% | – |
| Q4 2020 | $203,000 | – | 2,831 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orbimed Advisors | 10,039,691 | $69,274,000 | 1.12% |
| Baker Brothers Advisors | 10,123,824 | $69,854,000 | 0.40% |
| HHLR ADVISORS, LTD. | 583,333 | $4,025,000 | 0.08% |
| Rock Springs Capital Management LP | 368,959 | $2,546,000 | 0.06% |
| PDT Partners, LLC | 71,822 | $496,000 | 0.04% |
| Virtus ETF Advisers LLC | 13,048 | $90,000 | 0.04% |
| Corton Capital Inc. | 10,918 | $75,000 | 0.03% |
| GSA CAPITAL PARTNERS LLP | 23,201 | $160,000 | 0.02% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 24,238 | $167,000 | 0.01% |
| IndexIQ Advisors LLC | 56,750 | $392,000 | 0.01% |